Literature DB >> 6223739

Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity.

D S Chudwin, M J Cowan, D W Wara, A J Ammann.   

Abstract

Monoclonal antibodies which identify helper/inducer (OKT4) and cytotoxic/suppressor (OKT8) subsets of human T lymphocytes have recently been used to investigate immunoregulation in isolated cell populations, as well as in human disease states. However, the relationship between relative proportions of OKT4- and OKT8-positive blood lymphocytes and in vitro cellular immune function in patients with immunodeficiencies has not been studied extensively. We enumerated T-lymphocyte subsets with OKT4 and OKT8 antibodies, and measured proliferative responses to allogeneic cells in mixed lymphocyte culture (MLC) and to phytohemagglutinin (PHA), in peripheral blood mononuclear cells (PBMCs) from 60 patients with varying degrees of immunodeficiency and 20 healthy controls. Controls had 56.0 +/- 5.3% (mean +/- 1SD) OKT4-positive lymphocytes, 28.6 +/- 5.9% OKT8-positive lymphocytes, and an OKT4/8 ratio of 2.05 +/- 0.55. We defined as abnormal values of less than 40% OKT4-positive or greater than 45% OKT8-positive lymphocytes (3 SD below and above mean values, respectively), or an OKT4/8 ratio of less than 1.2. Patients with these abnormal percentages of T-lymphocyte subsets had significantly lower mean MLC and PHA responses (P less than 0.001), and higher incidences of abnormal MLC and PHA responses (P less than 0.01). Abnormal proportions of T-lymphocyte subsets correlated with low MLC and PHA responses in most immunodeficient patients, although some patients with low MLC and PHA responses had normal subset distributions. T-Cell subset proportions were heterogeneous among patients with the same diagnosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223739     DOI: 10.1016/0090-1229(83)90181-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  Predictive value of T-cell subset derangements in lung cancer.

Authors:  C Zabbe; J D Dewitte; P Lozach; J Clavier; P Youinou
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

2.  Lymphocyte subsets in urologic cancer patients.

Authors:  M Shaw; P Ray; M Rubenstein; P Guinan
Journal:  Urol Res       Date:  1987

3.  [Effect of PIND-AVI on various ratios of helper and suppressor T lymphocytes].

Authors:  T Schleich; H Stickl
Journal:  Klin Wochenschr       Date:  1986-11-17

4.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

5.  Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex.

Authors:  A J Ammann; M A Palladino; P Volberding; D Abrams; N L Martin; M Conant
Journal:  J Clin Immunol       Date:  1987-11       Impact factor: 8.317

6.  Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells.

Authors:  M J Cowan; D W Wara; P S Weintrub; H Pabst; A J Ammann
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

7.  In vitro mitogen responses and lymphocyte subpopulations in cheetahs.

Authors:  M Miller-Edge; M Worley
Journal:  Vet Immunol Immunopathol       Date:  1991-07       Impact factor: 2.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.